PRMT3, as a type I protein arginine methyltransferase, primarily catalyses the asymmetric dimethylation of arginine residues and plays a key role in cancer development through various mechanisms including cell metabolism and gene regulation. The gene discussed is PRMT3; the disease is cancer.